Chilton Investment Company’s AbbVie ABBV Stock Holding History

Chilton Investment Company’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.9M	Buy	17,920 +1,440	+9%	+$319K	0.09%	90
2025 Q4	$3.77M	Buy	16,480 +836	+5%	+$190K	0.08%	86
2025 Q3	$3.62M	Buy	15,644 +1,080	+7%	+$220K	0.07%	87
2025 Q2	$2.7M	Buy	14,564 +928	+7%	+$172K	0.06%	82
2025 Q1	$2.86M	Sell	13,636 -937	-6%	-$182K	0.07%	82
2024 Q4	$2.59M	Hold	14,573	–	–	0.07%	83
2024 Q3	$2.88M	Hold	14,573	–	–	0.08%	82
2024 Q2	$2.5M	Buy	14,573 +2,178	+18%	+$361K	0.07%	79
2024 Q1	$2.26M	Buy	12,395 +210	+2%	+$36.2K	0.06%	84
2023 Q4	$1.89M	Sell	12,185 -111	-0.9%	-$16.2K	0.06%	84
2023 Q3	$1.83M	Buy	12,296 +2,068	+20%	+$304K	0.06%	83
2023 Q2	$1.38M	Buy	10,228 +481	+5%	+$70.5K	0.04%	91
2023 Q1	$1.55M	Hold	9,747	–	–	0.05%	82
2022 Q4	$1.58M	Hold	9,747	–	–	0.05%	78
2022 Q3	$1.31M	Buy	9,747 +728	+8%	+$104K	0.04%	86
2022 Q2	$1.38M	Buy	9,019 +1,836	+26%	+$281K	0.04%	95
2022 Q1	$1.16M	Hold	7,183	–	–	0.03%	83
2021 Q4	$973K	Buy	7,183 +576	+9%	+$68K	0.02%	102
2021 Q3	$713K	Sell	6,607 -43	-0.6%	-$4.91K	0.02%	109
2021 Q2	$749K	Sell	6,650 -725	-10%	-$81.7K	0.02%	97
2021 Q1	$798K	Sell	7,375 -2,322	-24%	-$248K	0.02%	101
2020 Q4	$1.04M	Sell	9,697 -733	-7%	-$70.4K	0.03%	83
2020 Q3	$914K	Buy	10,430 +1,897	+22%	+$179K	0.03%	90
2020 Q2	$838K	Buy	+8,533	New	+$751K	0.03%	90
2019 Q1	–	Sell	-4,077	Closed	-$376K	–	119
2018 Q4	$376K	Sell	4,077 -141	-3%	-$12.4K	0.01%	109
2018 Q3	$399K	Buy	4,218 +1,318	+45%	+$125K	0.01%	114
2018 Q2	$269K	Hold	2,900	–	–	0.01%	121
2018 Q1	$274K	Hold	2,900	–	–	0.01%	124
2017 Q4	$280K	Hold	2,900	–	–	0.01%	114
2017 Q3	$258K	Sell	2,900 -121	-4%	-$9.21K	0.01%	123
2017 Q2	$219K	Buy	+3,021	New	+$203K	0.01%	131
2017 Q1	–	Sell	-4,825	Closed	-$302K	–	135
2016 Q4	$302K	Hold	4,825	–	–	0.01%	117
2016 Q3	$304K	Buy	4,825 +525	+12%	+$34K	0.01%	107
2016 Q2	$266K	Sell	4,300 -25,789	-86%	-$1.57M	0.01%	116
2016 Q1	$1.72M	Sell	30,089 -34,232	-53%	-$1.91M	0.06%	75
2015 Q4	$3.81M	Sell	64,321 -4,584	-7%	-$264K	0.13%	53
2015 Q3	$3.75M	Buy	68,905 +63,135	+1,094%	+$4.11M	0.13%	73
2015 Q2	$388K	Sell	5,770 -280	-5%	-$18.3K	0.01%	135
2015 Q1	$354K	Sell	6,050 -1,050	-15%	-$63.4K	0.01%	126
2014 Q4	$465K	Buy	7,100 +1,500	+27%	+$94.6K	0.02%	141
2014 Q3	$323K	Buy	+5,600	New	+$311K	0.01%	154
2014 Q2	–	Sell	-5,700	Closed	-$293K	–	122
2014 Q1	$293K	Sell	5,700 -1,200	-17%	-$60.6K	0.01%	151
2013 Q4	$364K	Buy	+6,900	New	+$339K	0.01%	146

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Chilton Investment Company's ABBV Position: Q1 2026 in Review

Chilton Investment Company increased its AbbVie (ABBV) stake by 8.7% in Q1 2026, buying an estimated $319K and bringing the position to 17,920 shares worth $3.9M. The position accounts for 0.09% of the portfolio, ranked #90.

Chilton Investment Company first reported a position in ABBV in Q4 2013 and has held it in 43 quarters since. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Chilton Investment Company held 17,920 shares of AbbVie worth $3.9M as of Q1 2026.
Chilton Investment Company bought 1,440 AbbVie shares in Q1 2026, an estimated $319K.
AbbVie made up 0.09% of Chilton Investment Company's portfolio in Q1 2026, its #90 holding.
Chilton Investment Company first reported a position in AbbVie in Q4 2013 and has held it in 43 quarters since.
4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Chilton Investment Company's 13F filing for Q1 2026, filed 15 May 2026.